Signaling pathways
-
BA5197 CCX-777Summary: CCX-777 is recruited as a partial agonist to ACKR3. -
BA5198 MK-5046Summary: MK-5046 is a potent, selective, orally active Bombesin receptor subtype 3 variant agonist.
-
BA5199 ML-18Summary: A nonapeptide belladonna peptide receptor subtype-3 (BRS-3) antagonist that inhibits lung cancer growth.
-
BA5200 BIM-26226Summary: BIM-26226 is a gastrin-releasing peptide that is a potent and selective antagonist.
-
BA5201 Bradykinin3 CitationSummary: Bradykinin is a potent endothelium-dependent vasodilator that lowers blood pressure. -
BA5202 SSR240612Summary: SSR240612 is a potent, orally available, specific non-peptide bradykinin B1 receptor antagonist.
-
BA5203 LobradimilSummary: Lobradimil (RMP7), a synthetic form of bradykinin (bradykinin) analog, is a potent and selective bradykinin B2 receptor agonist (0.54 nM).
-
BA5204 FulimetibantSummary: A bradykinin receptor antagonist.
-
BA5207 LY2828360Summary: LY2828360 is a slow-acting but very potent G protein-biased cannabinoid receptor 2 agonist.
-
BA5208 MonlunabantSummary: Monlunabant ((S)-MRI-1891) is a solid dispersion compound.